Empery Asset Management, LP 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Empery Asset Management, LP 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-20
09:47 am
Sale
2021-12-31 13G BriaCell Therapeutics Corp.
BCTX
Empery Asset Management, LP 33,333
2.520%
-760decrease
(-2.23%)
Filing
2021-03-02
12:06 pm
Purchase
2021-02-23 13G BriaCell Therapeutics Corp.
BCTX
Empery Asset Management, LP 34,094
8.890%
34,094increase
(New Position)
Filing